The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease

NCT03253965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-11-13

No results posted yet for this study

Summary

The purpose of this study is to determine how using auditory cues of a metronome and music at various frequencies impacts the gait mechanics in people with Parkinson's disease when walking over ground and on a treadmill.

The investigators will enroll a total of 40 participants: 30 subjects with a diagnosis of Parkinson's disease (10 in Stage 1, 10 in Stage 2, and 10 in Stage 3) and 10 unimpaired subjects.

Participants will complete 7 different treadmill walking conditions and overground walking conditions while the investigators measure step length, cadence, gait speed, and variability of movement.

Conditions

  • Parkinson Disease

Interventions

OTHER

Metronome Normal

Steps are timed with the beat of the metronome set to the subject's cadence

OTHER

Metronome Slow

Steps are timed with the beat of the metronome set to 85% of the subject's cadence

OTHER

Metronome Fast

Steps are timed with the beat of the metronome set to 115% of the subject's cadence

OTHER

Music Normal

Steps are timed with the beat of the music by a rhythm consistent with the subject's cadence

OTHER

Music Slow

Steps are timed with the beat of the music by a rhythm consistent with 85% of the subject's cadence

OTHER

Music Fast

Steps are timed with the beat of the music by a rhythm consistent with 115% of the subject's cadence

OTHER

No Auditory cueing

Steps are not timed with any auditory cue.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Guneet Chawla · University of North Carolina, Chapel Hill

  • Michael Lewek, PT, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03253965 on ClinicalTrials.gov